U-Blot® Research Grade Insulin AspartCat. No. WA2992$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Insulin AspartCat. No. WA2992
U-Blot® Research Grade InotuzumabCat. No. WA2991
U-Blot® Research Grade InolimomabCat. No. WA2990
U-Blot® Research Grade inlecitugCat. No. WA2989
U-Blot® Research Grade ingitamigCat. No. WA2988
U-Blot® Research Grade InfliximabCat. No. WA2987
U-Blot® Research Grade InezetamabCat. No. WA2986
U-Blot® Research Grade InebilizumabCat. No. WA2985
U-Blot® Research Grade IndusatumabCat. No. WA2984
U-Blot® Research Grade IndenebartCat. No. WA2983
U-Blot® Research Grade indemakitugCat. No. WA2982
U-Blot® Research Grade IndatuximabCat. No. WA2981